For applications in the pharmaceutical industry, Polaris prepares and carries out the verifications needed for FDA validation of the system.
During the design phase, the functional and design specifications are prepared based on the client URS, which, together with other design documents, are the basis for the successive qualification activities.
All designs take into account the final validation phase to which the system is submitted after installation, particularly for systems that have direct impact on the customer’s production (like solvent recovery units for internal use). Specifically, the managing system and the section of the plant designated for product control are adequately configured before reuse.
After the prefabrication activities, the qualification protocols are prepared (IQ, PQ), and are checked and approved by the client QA.
Before the plant start-up, all necessary verifications are carried out for installation, as well as for the functionality and the calibration of the elements included in the system.
To stay up-to-date on GMP and FDA standards, Polaris is associated with the ISPE (International Society for Pharmaceutical Engineering).